Transapical transcatheter aortic valve implantation in a high-risk patient with aortic and mitral regurgitation: usage of the JenaValve™ system
Author(s) -
Süleyman Sürer,
İlker İnce,
İbrahim Duvan,
Cengizhan Bayyurt,
Uğursay Kızıltepe
Publication year - 2016
Publication title -
the european research journal
Language(s) - English
Resource type - Journals
ISSN - 2149-3189
DOI - 10.18621/eurj.2016.5000197998
Subject(s) - medicine , regurgitation (circulation) , cardiology , mitral regurgitation , aortic valve , aortic valve insufficiency , mitral valve
JenaValve TM system is a second-generation transcatheter heart valve that provides a successful deployment not only in calcified stenotic aortic valves but also in non-calcified, severe regurgitant aortic valves. We performed a transapical transcatheter aortic valve implantation procedure using this system without any procedure-related complications in a 75-year-old woman with multiple co-morbidity factors, who had both mitral and aortic regurgitation, and low ejection fraction.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom